Anjan Nan

1.6k total citations
25 papers, 1.3k citations indexed

About

Anjan Nan is a scholar working on Molecular Biology, Biomaterials and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Anjan Nan has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Biomaterials and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Anjan Nan's work include Nanoparticle-Based Drug Delivery (8 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Lanthanide and Transition Metal Complexes (3 papers). Anjan Nan is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Lanthanide and Transition Metal Complexes (3 papers). Anjan Nan collaborates with scholars based in United States, United Kingdom and China. Anjan Nan's co-authors include Hamidreza Ghandehari, Amitava Mitra, Bruce R. Line, Sang Jun Son, Xia Bai, Sang Bok Lee, Simon L. Croft, Vanessa Yardley, John C. Papadimitriou and Jiachen Zhuo and has published in prestigious journals such as Nano Letters, Cancer Research and Journal of Controlled Release.

In The Last Decade

Anjan Nan

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anjan Nan United States 19 618 495 384 259 196 25 1.3k
Robert Pola Czechia 19 691 1.1× 529 1.1× 647 1.7× 152 0.6× 193 1.0× 58 1.4k
In-San Kim South Korea 14 712 1.2× 587 1.2× 639 1.7× 233 0.9× 90 0.5× 16 1.4k
Siti M. Janib United States 10 681 1.1× 417 0.8× 634 1.7× 310 1.2× 88 0.4× 11 1.4k
Anat Eldar‐Boock Israel 20 560 0.9× 705 1.4× 689 1.8× 262 1.0× 107 0.5× 37 1.7k
Marloes M. J. Kamphuis Netherlands 20 682 1.1× 535 1.1× 419 1.1× 166 0.6× 80 0.4× 25 1.5k
James Z. Hui United States 11 610 1.0× 550 1.1× 700 1.8× 287 1.1× 212 1.1× 15 1.4k
Sharon M. Sagnella Australia 27 786 1.3× 774 1.6× 470 1.2× 216 0.8× 49 0.3× 45 1.8k
Magdalena Swierczewska United States 22 535 0.9× 975 2.0× 1.1k 2.9× 500 1.9× 219 1.1× 32 2.2k
Yingjuan Lu United States 18 622 1.0× 876 1.8× 509 1.3× 213 0.8× 150 0.8× 34 1.8k
Michal Pechar Czechia 26 1.1k 1.8× 908 1.8× 792 2.1× 232 0.9× 257 1.3× 76 2.2k

Countries citing papers authored by Anjan Nan

Since Specialization
Citations

This map shows the geographic impact of Anjan Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anjan Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anjan Nan more than expected).

Fields of papers citing papers by Anjan Nan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anjan Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anjan Nan. The network helps show where Anjan Nan may publish in the future.

Co-authorship network of co-authors of Anjan Nan

This figure shows the co-authorship network connecting the top 25 collaborators of Anjan Nan. A scholar is included among the top collaborators of Anjan Nan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anjan Nan. Anjan Nan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ghandehari, Hamidreza, et al.. (2013). Riboflavin-Targeted Polymer Conjugates for Breast Tumor Delivery. Pharmaceutical Research. 30(7). 1799–1812. 29 indexed citations
3.
Yap, Jeremy L., Xiaobo Cao, Kenno Vanommeslaeghe, et al.. (2012). Relaxation of the rigid backbone of an oligoamide-foldamer-based α-helix mimetic: identification of potent Bcl-xL inhibitors. Organic & Biomolecular Chemistry. 10(15). 2928–2928. 54 indexed citations
6.
Dowling, Matthew B., Linjie Li, Juhee Park, et al.. (2010). Multiphoton-Absorption-Induced-Luminescence (MAIL) Imaging of Tumor-Targeted Gold Nanoparticles. Bioconjugate Chemistry. 21(11). 1968–1977. 20 indexed citations
7.
Daniel, Marie‐Christine, Ömer Aras, Mark F. Smith, Anjan Nan, & Thorsten Fleiter. (2010). Targeted in-vivo computed tomography (CT) imaging of tissue ACE using concentrated lisinopril-capped gold nanoparticle solutions. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 7674. 76740J–76740J. 4 indexed citations
8.
Nan, Anjan, et al.. (2008). HPMA Copolymer–Doxorubicin–Gadolinium Conjugates: Synthesis, Characterization, and in vitro Evaluation. Macromolecular Bioscience. 8(8). 741–748. 26 indexed citations
9.
Son, Sang Jun, Xia Bai, Anjan Nan, Hamidreza Ghandehari, & Sang Bok Lee. (2006). Template synthesis of multifunctional nanotubes for controlled release. Journal of Controlled Release. 114(2). 143–152. 96 indexed citations
10.
Mitra, Amitava, Anjan Nan, John C. Papadimitriou, Hamidreza Ghandehari, & Bruce R. Line. (2006). Polymer-peptide conjugates for angiogenesis targeted tumor radiotherapy. Nuclear Medicine and Biology. 33(1). 43–52. 59 indexed citations
11.
Mitra, Amitava, Anjan Nan, Bruce R. Line, & Hamidreza Ghandehari. (2006). Nanocarriers for Nuclear Imaging and Radiotherapy of Cancer. Current Pharmaceutical Design. 12(36). 4729–4749. 90 indexed citations
12.
Mitra, Amitava, et al.. (2006). Polymeric conjugates of mono- and bi-cyclic αVβ3 binding peptides for tumor targeting. Journal of Controlled Release. 114(2). 175–183. 72 indexed citations
13.
Nan, Anjan, et al.. (2006). Macrophage Targeted N-(2-Hydroxypropyl)methacrylamide Conjugates for Magnetic Resonance Imaging. Molecular Pharmaceutics. 3(5). 550–557. 29 indexed citations
14.
Nan, Anjan, Hamidreza Ghandehari, Carla Hebert, et al.. (2005). Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck. Journal of drug targeting. 13(3). 189–197. 36 indexed citations
15.
Nan, Anjan, et al.. (2005). Successful treatment of persistent voiding dysfunction following Tension Free Vaginal Tape procedure. Journal of Obstetrics and Gynaecology. 25(1). 79–79. 1 indexed citations
16.
Mitra, Amitava, et al.. (2004). Technetium-99m-Labeled N-(2-Hydroxypropyl) Methacrylamide Copolymers: Synthesis, Characterization, and in Vivo Biodistribution. Pharmaceutical Research. 21(7). 1153–1159. 46 indexed citations
17.
Mitra, Amitava, et al.. (2004). Targeting tumor angiogenic vasculature using polymer–RGD conjugates. Journal of Controlled Release. 102(1). 191–201. 117 indexed citations
18.
Huang, Yuan, et al.. (2004). HPMA copolymer-mitoxantrone conjugates for targeted cancer chemotherapy. Journal of Drug Delivery Science and Technology. 14(3). 187–191. 6 indexed citations
19.
Nan, Anjan, Simon L. Croft, Vanessa Yardley, & Hamidreza Ghandehari. (2003). Targetable water-soluble polymer-drug conjugates for the treatment of visceral leishmaniasis. Journal of Controlled Release. 94(1). 115–127. 54 indexed citations
20.
Nan, Anjan, N. P. Dhammika Nanayakkara, Larry Walker, et al.. (2001). N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers for targeted delivery of 8-aminoquinoline antileishmanial drugs. Journal of Controlled Release. 77(3). 233–243. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026